Search

Your search keyword '"Hoft, Daniel F"' showing total 514 results

Search Constraints

Start Over You searched for: Author "Hoft, Daniel F" Remove constraint Author: "Hoft, Daniel F"
514 results on '"Hoft, Daniel F"'

Search Results

3. Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials

5. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

7. Tristetraprolin mediates immune evasion of mycobacterial infection in macrophages.

8. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial

10. Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In Vivo

11. 2395. An Interim Report of the Safety, Reactogenicity, and Immunogenicity of a Self-amplifying mRNA (samRNA) COVID-19 Vaccine GRT-R910 as a Booster in Healthy Adults

12. Senescent T cells within suppressive tumor microenvironments: emerging target for tumor immunotherapy

14. Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14.

15. Safety and Immunogenicity of a Delayed Heterologous Avian Influenza A(H7N9) Vaccine Boost Following Different Priming Regimens: A Randomized Clinical Trial.

16. Homodimeric Granzyme A Opsonizes Mycobacterium tuberculosis and Inhibits Its Intracellular Growth in Human Monocytes via Toll-Like Receptor 4 and CD14

17. Identification of immunodominant T cell epitopes induced by natural Zika virus infection

19. Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

22. A New Recombinant Bacille Calmette-Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers

36. Corrigendum: The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

37. A Multicenter, Controlled Human Infection Study of Influenza A(H1N1)pdm09 in Healthy Adults

38. The Vacc-SeqQC project: Benchmarking RNA-Seq for clinical vaccine studies

40. A Multi-Center, Controlled Human Infection Study of Influenza A (H1N1)pdm09 in Healthy Adults

41. Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial

43. The Vacc-SeqQC Project: Benchmarking RNA-Seq for Clinical Vaccine Studies

44. Plasmalogen Loss in Sepsis and SARS-CoV-2 Infection

47. Impact of BCG vaccination on the repertoire of human γδ T cell receptors.

50. Effects of BCG vaccination on donor unrestricted T cells in two prospective cohort studies

Catalog

Books, media, physical & digital resources